Ascendis Pharma A/S
SWB:A71
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Ascendis Pharma A/S
SWB:A71
|
DK |
|
Northeast Community Bancorp Inc
NASDAQ:NECB
|
US |
|
E
|
Emerson Electric Co
DUS:EMR
|
US |
|
B
|
Build-A-Bear Workshop Inc
F:FPW
|
US |
|
R
|
Realty Income Corp
F:RY6
|
US |
|
Lifetime Brands Inc
F:LH1
|
US |
|
E
|
Eastman Chemical Co
SWB:EAC
|
US |
|
S
|
Subsea 7 SA
DUS:SOC
|
UK |
|
H
|
Home Depot Inc
F:HDI
|
US |
|
Mitsubishi HC Capital Inc
TSE:8593
|
JP |
|
W
|
W W Grainger Inc
F:GWW
|
US |
|
R
|
Royal Caribbean Cruises Ltd
XMUN:RC8
|
US |
|
M
|
Mondelez International Inc
XHAM:KTF
|
US |
Wall St Price Targets
A71 Price Targets Summary
Ascendis Pharma A/S
According to Wall Street analysts, the average 1-year price target for A71 is 262.81 EUR with a low forecast of 222.38 EUR and a high forecast of 320.59 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is A71's stock price target?
Price Target
262.81
EUR
According to Wall Street analysts, the average 1-year price target for A71 is 262.81 EUR with a low forecast of 222.38 EUR and a high forecast of 320.59 EUR.
What is the Revenue forecast for Ascendis Pharma A/S?
Projected CAGR
24%
Over the last 12 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 24%.
What is the Gross Profit forecast for Ascendis Pharma A/S?
Projected CAGR
25%
The compound annual growth rate for Gross Profit over the next 8 years is 25%.
